ValueScreener

Oracle Corporation (ORCL): investment thesis checklist

What a value investor writing down why they own Oracle Corporation would be relying on, read from its filings: the figures that have carried the business, the lines a reader might set on them, and the published tests it meets today. A list to write against, not a view on the company.

1. The figures the case would rest on

  • Return on equity: 40.2% in FY2026; between 7.7% and 792.5% over 9 filed years, median 60.8%. Does the thesis need it to stay inside that range?
  • Free cash flow yield: -3.6% in FY2026; between -3.6% and 6.9% over 10 filed years, median 4.7%. Does the thesis need it to stay inside that range?
  • Price to earnings: 38.73x in FY2026; between 17.04x and 54.96x over 10 filed years, median 30.71x. Does the thesis need it to stay inside that range?
  • Operating margin: 30.6% in FY2026; between 25.7% and 37.6% over 10 filed years, median 32.2%. Does the thesis need it to stay inside that range?
  • Revenue growth, 5-year CAGR: 10.7% in FY2026; between 0.4% and 10.7% over 10 filed years, median 2.1%. Does the thesis need it to stay inside that range?
  • Share count change: 1.7% in FY2026; between -11.9% and 2.1% over 10 filed years, median -1.4%. Does the thesis need it to stay inside that range?

2. What must stay true: guardrails a reader might set

Each line is drafted from Oracle Corporation's own current figure, never from a level we think a business should clear, and replayed over its filed years. They are a reader's to keep, edit or drop.

  • Debt to Equity stays at or below 4.92x

    Today 3.94x. Replayed over 1 filed years, it held in every one.

  • Revenue Growth 1Y stays at or above 0%

    Today 17.35%. Replayed over 10 filed years, it would have broken in 1; most recently FY2020, at -1.11% (10-K, filed 2020-06-22).

  • Dividend Rate stays at or above $1.98

    Today $2.00. This indicator depends on inputs (market price, multi-statement composites) whose history is not deep enough to re-derive it with the same formula as the live value, so no honest retro-test exists for it.

Draft your own thesis on ORCL, free

3. What would break it

  • A filed year in which debt to equity rose above 4.92x.
  • A filed year in which revenue growth 1y fell below 0%.
  • A filed year in which dividend rate fell below $1.98.

4. The published tests it meets today

Of 30 tests value investors published: 0 met, 29 not met, 1 we could not complete. Counts, never a score.

What this cannot tell you

What the numbers say today, not the day one stops being true. The reasons are not written down.

An account adds

One email the night a number you wrote down breaks. Silence otherwise.

No card. 30 free days, and nothing is charged unless you choose a plan.

How this is computed

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map
  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.